Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Alcohol, Illicit Drugs, and Suicide Mortality Trends Stratified by Age, Gender, and Race for 2006-2019.
Journal: American journal of lifestyle medicine
Published: September 19, 2023
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology.
Journal: ACS medicinal chemistry letters
Published: May 11, 2018
Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology.
Journal: Bioorganic & medicinal chemistry letters
Published: February 22, 2018
Corrigendum to "1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents" [Bioorg. Med. Chem. Lett. 27 (2017) 4471-4477].
Journal: Bioorganic & medicinal chemistry letters
Published: February 13, 2018
1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents.
Journal: Bioorganic & medicinal chemistry letters
Published: June 20, 2017
Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritis.
Journal: Bioorganic & medicinal chemistry letters
Published: February 20, 2017
Discovery of novel BTK inhibitors with carboxylic acids.
Journal: Bioorganic & medicinal chemistry letters
Published: November 08, 2016
Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis.
Journal: ACS medicinal chemistry letters
Published: December 01, 2015
Dissecting Therapeutic Resistance to ERK Inhibition.
Journal: Molecular cancer therapeutics
Published: March 27, 2015
Discovery of hydroxyaniline amides as selective Extracellular Regulated Kinase (Erk) inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: December 03, 2014
Discovery of novel, dual mechanism ERK inhibitors by affinity selection screening of an inactive kinase.
Journal: Journal of medicinal chemistry
Published: October 15, 2014
Last Updated: 09/26/2026